Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
9138studies shown
Showing 6,637-6,648 of 9,138
Drug study icon
TerminatedNCT01122927

Safety study of aripiprazole in schizophrenia

This study has public registry information in the United States, in Bulgaria, in Croatia, .... It is testing aripiprazole for schizophrenia.

Multiple locations, including Dothan
Bipolarity, SchizophreniaOtherFrom 10 Years to 17 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
Other study type icon
CompletedNCT03238326

Open-Label Flexible-dose Brexpiprazole for schizophrenia

This study is completed in the United States, in France, in Italy, .... It is testing Open-Label Flexible-dose Brexpiprazole for schizophrenia.

Multiple locations, including Dothan
SchizophreniaOtherFrom 13 Years to 17 Years
Countries
United States, France, Italy, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia